A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.
Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT, Tura S, Fischer T, Deininger MW, Schiffer CA, Baccarani M, Gratwohl A, Hochhaus A, Hoelzer D, Fernandes-Reese S, Gathmann I, Capdeville R, O'Brien SG.
Ottmann OG, et al. Among authors: o brien sg.
Blood. 2002 Sep 15;100(6):1965-71. doi: 10.1182/blood-2001-12-0181.
Blood. 2002.
PMID: 12200353
Free article.
Clinical Trial.